FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.22
+3.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 53.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.06x
- Price / sales
- 9.14x
- Price / cash flow
- -5.39x
Enterprise value
- Enterprise value
- $518.7M
- EV / sales
- 5.64x
- EV / EBITDA
- -2.81x
- EV / EBIT
- -2.63x
- Market cap
- $840.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026